These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18056459

  • 21. Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila.
    Zhao YM, Chen X, Sun H, Yuan ZG, Ren GL, Li XX, Lu J, Huang BQ.
    Cell Res; 2006 Jun; 16(6):566-76. PubMed ID: 16775628
    [Abstract] [Full Text] [Related]

  • 22. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA).
    Kim MS, Baek JH, Chakravarty D, Sidransky D, Carrier F.
    Exp Cell Res; 2005 May 15; 306(1):94-102. PubMed ID: 15878336
    [Abstract] [Full Text] [Related]

  • 23. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A.
    Galiová G, Bártová E, Raska I, Krejcí J, Kozubek S.
    Eur J Cell Biol; 2008 May 15; 87(5):291-303. PubMed ID: 18396346
    [Abstract] [Full Text] [Related]

  • 24. HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53.
    Hallgren O, Gustafsson L, Irjala H, Selivanova G, Orrenius S, Svanborg C.
    Apoptosis; 2006 Feb 15; 11(2):221-33. PubMed ID: 16502260
    [Abstract] [Full Text] [Related]

  • 25. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila.
    Zhao Y, Lu J, Sun H, Chen X, Huang W, Tao D, Huang B.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):811-6. PubMed ID: 15607742
    [Abstract] [Full Text] [Related]

  • 26. Histone deacetylation as a target for radiosensitization.
    Cerna D, Camphausen K, Tofilon PJ.
    Curr Top Dev Biol; 2006 Jan 28; 73():173-204. PubMed ID: 16782459
    [Abstract] [Full Text] [Related]

  • 27. Histone H2A mobility is regulated by its tails and acetylation of core histone tails.
    Higashi T, Matsunaga S, Isobe K, Morimoto A, Shimada T, Kataoka S, Watanabe W, Uchiyama S, Itoh K, Fukui K.
    Biochem Biophys Res Commun; 2007 Jun 08; 357(3):627-32. PubMed ID: 17445770
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.
    Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, Craddock C, Turner BM.
    Leukemia; 2005 Oct 08; 19(10):1751-9. PubMed ID: 16121216
    [Abstract] [Full Text] [Related]

  • 30. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K, Takahashi A, Kaneko M, Sugeno H, Hirasawa N, Hong J, Zee O, Ohuchi K.
    Life Sci; 2007 Mar 06; 80(13):1213-20. PubMed ID: 17258775
    [Abstract] [Full Text] [Related]

  • 31. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J, Du C, Kang J, Wang J.
    Chem Biol Interact; 2008 Jan 10; 171(1):26-36. PubMed ID: 17961528
    [Abstract] [Full Text] [Related]

  • 32. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors.
    Lu Q, Wang DS, Chen CS, Hu YD, Chen CS.
    J Med Chem; 2005 Aug 25; 48(17):5530-5. PubMed ID: 16107152
    [Abstract] [Full Text] [Related]

  • 33. Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island.
    Koizume S, Tachibana K, Shiraishi M.
    Biol Chem; 2003 May 25; 384(5):787-90. PubMed ID: 12817475
    [Abstract] [Full Text] [Related]

  • 34. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG, Kypreou KP, Topakas GN, Karchilaki IN, Stavropoulos-Giokas C, Sekeri-Pataryas KE.
    Ann N Y Acad Sci; 2007 Nov 25; 1119():64-71. PubMed ID: 18056955
    [Abstract] [Full Text] [Related]

  • 35. alpha-Lactalbumin, engineered to be nonnative and inactive, kills tumor cells when in complex with oleic acid: a new biological function resulting from partial unfolding.
    Pettersson-Kastberg J, Mossberg AK, Trulsson M, Yong YJ, Min S, Lim Y, O'Brien JE, Svanborg C, Mok KH.
    J Mol Biol; 2009 Dec 18; 394(5):994-1010. PubMed ID: 19766653
    [Abstract] [Full Text] [Related]

  • 36. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter.
    Astrand C, Belikov S, Wrange O.
    Exp Cell Res; 2009 Sep 10; 315(15):2604-15. PubMed ID: 19463811
    [Abstract] [Full Text] [Related]

  • 37. Analysis of checkpoint responses to histone deacetylase inhibitors.
    Beamish H, Warrener R, Gabrielli BG.
    Methods Mol Biol; 2004 Sep 10; 281():245-59. PubMed ID: 15220534
    [Abstract] [Full Text] [Related]

  • 38. Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression.
    Taura K, Yamamoto Y, Nakajima A, Hata K, Uchinami H, Yonezawa K, Hatano E, Nishino N, Yamaoka Y.
    J Gene Med; 2004 May 10; 6(5):526-36. PubMed ID: 15133763
    [Abstract] [Full Text] [Related]

  • 39. 2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.
    Mahboobi S, Sellmer A, Höcher H, Garhammer C, Pongratz H, Maier T, Ciossek T, Beckers T.
    J Med Chem; 2007 Sep 06; 50(18):4405-18. PubMed ID: 17691763
    [Abstract] [Full Text] [Related]

  • 40. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.
    Yasukawa K, Sawamura D, Goto M, Nakamura H, Shimizu H.
    Br J Dermatol; 2007 Oct 06; 157(4):662-9. PubMed ID: 17711521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.